China Begins Crackdown On Unapproved Clinical Gene Sequencing
This article was originally published in PharmAsia News
Executive Summary
China's FDA has begun a crackdown on use of gene sequencing in clinical settings and ordered a halt to all uses that have not been approved by the CFDA.